Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | NA | NA |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.01 | 1.74 |
NAV | ₹31.89 | ₹82.07 |
Fund Started | 11 Jan 2010 | 17 Nov 2003 |
Fund Size | ₹116.61 Cr | ₹3406.09 Cr |
Exit Load | Exit Load for units in excess of 10% of the investment,0.25% will be charged for redemption within 7 days. | Exit load for units in excess of 15% of the investment, 1% will be charged for redemption within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.14% | 7.05% |
3 Year | 8.39% | 12.32% |
5 Year | 7.21% | 12.32% |
1 Year
3 Year
5 Year
Equity | 10.17% | 20.96% |
Cash | 24.24% | 3.94% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Titan Company Ltd. | 2.29% |
Tata Consultancy Services Ltd. | 2.10% |
TVS Motor Company Ltd. | 1.66% |
UNO Minda Ltd. | 1.06% |
Cholamandalam Investment and Finance Company Ltd. | 0.99% |
Godrej Consumer Products Ltd. | 0.83% |
HDFC Bank Ltd. | 0.80% |
Axis Bank Ltd. | 0.29% |
Indusind Bank Ltd. | 0.15% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 2.50% |
HDFC Bank Ltd. | 2.00% |
State Bank of India | 1.19% |
Axis Bank Ltd. | 1.14% |
Reliance Industries Ltd. | 1.04% |
Infosys Ltd. | 0.78% |
Larsen & Toubro Ltd. | 0.76% |
Bharti Airtel Ltd. | 0.76% |
ITC Ltd. | 0.74% |
Sun Pharmaceutical Industries Ltd. | 0.74% |
Name | Nishita Shah | Dhruv Muchhal |
Start Date | 24 May 2023 | 14 Sep 2023 |
Name
Start Date
Description | The Scheme seeks to generate regular returns through investment predominantly in debt instruments. The secondary objective of the Scheme is to generate long-term capital appreciation by investing a portion of the Scheme's total assets in equity | The scheme seeks to generate income/capital appreciation by investing primarily in debt securities, money market instruments and moderate exposure to equities. |
Launch Date | 11 Jan 2010 | 17 Nov 2003 |
Description
Launch Date